journal article·2017-04

A NIR turn-on fluorescent probe applied in cytochrome P450 reductase detection and hypoxia imaging in tumor cells

Lei Cui, Yanping Shi, Shuping Zhang, Luliang Yan, Huan Zhang, Zhenran Tian, Yingying Gu, Ting Guo, Junhai Huang

Dyes and Pigments· Volume 139
Publisher page

Abstract

Abstract In vivo monitoring of the hypoxic area is urgently required. Near infrared (NIR) fluorescence-active fluorophores with excellent photo stability are preferable for in vivo imaging. A novel rational designed turn-on fluorescent probe with high selectivity and long-wavelength was synthesized which was applied in bioreductase (cytochrome P450 reductase which overexpressed in tumor cells) and hypoxia detection. The NIR probe ( AZO-DCM ) is based on a photo stability fluorophore dicyanomethylene-4 H -pyran dye ( DCM ) with an azo bond as probe quencher and hypoxic trigger. After reacted with cytochrome P450 reductase, azo bond was cleaved and DCM released with fluorescent on. The designed probe showed high anti-interference ability which cannot disturb by many interfering substances, such as biothiols, inorganic salts (included sulfite salt) and amino acid. AZO-DCM performed good selectivity and sensitivity to cytochrome P450 reductase and hypoxia. The fluorescent intensity was increased more than 150-fold after response to cytochrome P450 reductase and NADH system in 4 min. The reaction mechanism also proved by HPLC experiment. Probe AZO-DCM displayed excellent properties in identifying different hypoxic status of tumor cells in vivo .
Source: openaire · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Cancer, Hypoxia, and Metabolism · Eicosanoids and Hypertension Pharmacology

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (30)

Show source-provided references
1. Targeting hypoxia in cancer therapy10.1038/nrc3064 ↗
2. Hypoxia and radiation therapy: past history, ongoing research, and future promise10.2174/156652409788167087 ↗
3. Utilising a hypoxia-inducible suicide gene therapy strategy in combination with radiation to target prostate cancer cells
4. Hypoxia inducible factor (HIF): its central role in renal cell cancer targeted therapy10.1016/j.urolonc.2008.08.006 ↗
5. Oxygen therapy in critical illness: precise control of arterial oxygenation and permissive hypoxemia10.1097/CCM.0b013e31826a44f6 ↗
6. Imaging of hypoxia in human tumors with [F-18] fluoromisonidazole10.1016/0360-3016(92)91001-4 ↗
7. Mechanisms of blood flow and hypoxia production in rat 9L-epigastric tumors10.2478/tumor-2012-0001 ↗
8. Dynamic contrast-enhanced-MRI of tumor hypoxia10.1002/mrm.23014 ↗
9. Imaging tumor hypoxia to advance radiation oncology10.1089/ars.2013.5759 ↗
10. Tissue injury and hypoxia promote malignant progression of prostate cancer by inducing CXCL13 expression in tumor myofibroblasts10.1073/pnas.1416498111 ↗
11. Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix
12. Tumor hypoxia and malignant progression
13. Enhanced response speed and selectivity of fluorescein-based H2S probe via the cleavage of nitrobenzene sulfonyl ester assisted by ortho aldehyde groups10.1016/j.bios.2016.08.018 ↗
14. An ESIPT based fluorescent probe for highly selective and ratiometric detection of periodate10.1016/j.bios.2014.08.005 ↗
15. A lysosome-targeting fluorescence off-on probe for imaging of nitroreductase and hypoxia in live cells
16. Efficient two-photon fluorescent probe for nitroreductase detection and hypoxia imaging in tumor cells and tissues10.1021/acs.analchem.5b03336 ↗
17. A cresyl violet-based fluorescent off-on probe for the detection and imaging of hypoxia and nitroreductase in living organisms10.1002/asia.201402364 ↗
18. A highly sensitive long-wavelength fluorescence probe for nitroreductase and hypoxia: selective detection and quantification10.1039/c3cc45367g ↗
19. A new prodrug-derived ratiometric fluorescent probe for hypoxia: high selectivity of nitroreductase and imaging in tumor cell10.1021/ol102975t ↗
20. Hypoxia-Sensitive fluorescent probes for in vivo real-time fluorescence imaging of acute ischemia10.1021/ja105937q ↗
21. Development of azo-based fluorescent probes to detect different levels of hypoxia10.1002/anie.201305784 ↗
22. A turn-on fluorescent probe for tumor hypoxia imaging in living cells10.1039/C5CC05518K ↗
23. In situ ratiometric quantitative tracing of intracellular leucine aminopeptidase activity via an activatable near-infrared fluorescent probe10.1021/acsami.6b10238 ↗
24. In vivo and in situ tracking cancer chemotherapy by highly photostable NIR fluorescent theranostic prodrug10.1021/ja412380j ↗
25. A dinuclear iridium(III) complex as a visual specific phosphorescent probe for endogenous sulphite and bisulphite in living cells10.1039/c3sc52301b ↗
26. A coumarin-quinolinium-based fluorescent probe for ratiometric sensing of sulfite in living cells10.1039/c4ob00132j ↗
27. Colorimetric and ratiometric fluorescent detection of sulfite in water via cationic surfactant-promoted addition of sulfite to alpha,beta-unsaturated ketone10.1016/j.aca.2013.06.020 ↗
28. Colorimetric and luminescent dual-signaling responsive probing of thiols by a ruthenium(II)-azo complex10.1016/j.jinorgbio.2012.12.019 ↗
29. Thiol-specific phosphorescent imaging in living cells with an azobis(2,2[prime or minute]-bipyridine)-bridged dinuclear iridium(iii) complex10.1039/c3cc38687b ↗
30. Ruthenium complexes containing an azobipyridine ligand as redox-responsive molecular switches10.1246/cl.1996.847 ↗